Graft Programmed Death Ligand 1 Expression as a Marker for Transplant Rejection Following Anti–Programmed Death 1 Immunotherapy for Recurrent Liver Tumors

Guo‐Ming Shi, Jiping Wang, Xiao‐Wu Huang, Xiao‐Yong Huang, Yi‐Feng He, Yuan Ji, Yi Chen, Dong Wu, Jia‐Cheng Lu, Qi‐Man Sun, Wei‐Ren Liu, Ting Wang, Liu‐Xiao Yang, Ying‐Yong Hou, Ying‐Hong Shi, Jian Sun, Yong‐Sheng Xiao, Zheng Wang, Jia Fan, Monica M. Bertagnolli, Jian Zhou – 8 September 2020

Dextroplantation of Left Liver Graft in Infants

Sung Woo Ahn, Nam‐Joon Yi, Hyo‐Cheol Kim, Hye Young Ahn, Suk Kyun Hong, Jeong‐Moo Lee, Jae‐Hyung Cho, Ung Sik Jin, Hak Chang, Myungsu Lee, Saebeom Hur, Hwan Jun Jae, Chul‐Woo Jung, Seong‐Mi Yang, Jae Sung Ko, Kwang‐Woong Lee, Kyung‐Suk Suh – 8 September 2020 – The position of the left side liver graft is important, and it could lead to complications of the hepatic vein (HV) and portal vein (PV), especially in a small child using a variant left lateral section (vLLS) graft.

The Apelin–Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis

Lixian Chen, Tianhao Zhou, Tori White, April O'Brien, Sanjukta Chakraborty, Suthat Liangpunsakul, Zhihong Yang, Lindsey Kennedy, Romil Saxena, Chaodong Wu, Fanyin Meng, Qiaobing Huang, Heather Francis, Gianfranco Alpini, Shannon Glaser – 7 September 2020

Internet Published Policies Regarding Liver Transplant Eligibility and Substance Use in United States Transplant Centers

Margarita N. German, Jason L. Eccleston, Diego A. Tamez, Patrick L. Remington, Michael R. Lucey – 7 September 2020 – Liver transplant centers in the United States retain great autonomy in determining eligibility criteria for a liver transplant. This study aims to define the availability and content of liver transplant centers' publicly available Internet policies regarding eligibility criteria for liver transplant.

Subscribe to